EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation

Ali Nabavi-Rad, Shaghayegh Jamshidizadeh, Mahsa Azizi, Abbas Yadegar, Karen Robinson, Tanya M Monaghan, Mohammad Reza Zali

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1171469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Ali Nabavi-Rad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical …. Hauptthemen laut MEDLINE: Helicobacter pylori, Levilactobacillus brevis, Helicobacter Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahid Beheshti University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Owing to the emergence and spread of multidrug resistance mechanisms in Helicobacter pylori , achieving a successful eradication has become exceedingly difficult. Thus, this study for the first time determines the effect of a combination of vitamin D3 and probiotic on the pathogenesis and treatment of H. pylori .

Methods

We established an in vitro experimental system using AGS human gastric carcinoma cells and explored the synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on H. pylori . Live and pasteurized L. brevis , L. brevis -derived membrane vesicles (MVs), and L. brevis cell-free supernatant (CFS), as well as their combination with vitamin D3 were used during this study. We assessed the anti-inflammatory and anti-oxidative effects of these combinations using RT-qPCR and ELISA, respectively. We further performed an adhesion assay to evaluate the influence of L. brevis and vitamin D3 on the adherence rate of H. pylori to AGS cells.

Results

Our results demonstrated that L. brevis and vitamin D3 possess anti-inflammatory and anti-oxidative effects against H. pylori infection in AGS cells. The combination of vitamin D3 with the probiotic strain (particularly live L. brevis and its CFS) can more efficiently reduce the expression of pro-inflammatory cytokines IL-6, IL-8, IFN-γ, and TNF-α in the AGS cells. Moreover, vitamin D3 and L. brevis exhibited an additive impact preserving the integrity of the epithelial barrier by increasing the expression of the tight junction protein ZO-1. Furthermore, this combination can potentially reduce H. pylori adherence to AGS cells.

Conclusions

This study indicates the advantage of combining vitamin D3 and probiotic to attenuate H. pylori -induced inflammation and oxidative stress. Consequently, probiotic and vitamin D3 co-supplementation can be considered as a novel therapeutic approach to manage and prevent H. pylori infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriLevilactobacillus brevisHelicobacter InfectionsHumansCholecalciferolEpithelial CellsInflammationAnti-Inflammatory AgentsGastric Mucosa

Stichwörter der Autor:innen

AGS cellsHelicobacter pyloriLevilactobacillus brevisextracellular vesiclessynergistic effectvitamin D3

Substanzen

CholecalciferolAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • National Institute for Health Research Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom.
  • Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Förderung

  • Shahid Beheshti University of Medical Sciences

Zitieren

APA

Nabavi-Rad, A., Jamshidizadeh, S., Azizi, M., Yadegar, A., Robinson, K., Monaghan, T. M., & Zali, M. R. (2023). The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1171469

Vancouver

Nabavi-Rad A, Jamshidizadeh S, Azizi M, Yadegar A, Robinson K, Monaghan TM, et al. The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1171469

BibTeX
@article{NabaviRad2023,
  author = {Nabavi-Rad, Ali and Jamshidizadeh, Shaghayegh and Azizi, Mahsa and Yadegar, Abbas and Robinson, Karen and Monaghan, Tanya M and Zali, Mohammad Reza},
  title = {The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1171469}
}
Kostenlos starten →